Cardiac involvement with lymphoma: A review of the literature

被引：58

作者：

O'Mahony, Deirdre ^{[1
]}

Peikarz, Richard L. ^{[2
]}

Bandettini, W. Patricia ^{[3
]}

Arai, Andrew E. ^{[3
]}

Wilson, Wyndham H. ^{[1
]}

Bates, Susan E. ^{[2
]}

机构：

[1] NCI, Metab Branch, NIH, Bethesda, MD 20892 USA

[2] NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA

[3] NHLBI, NIH, Bethesda, MD 20892 USA

来源：

CLINICAL LYMPHOMA & MYELOMA | 2008年 / 8卷 / 04期

基金：

美国国家卫生研究院;

关键词：

bortezomib; diffuse large B-cell lymphoma; metastasis; mycosis fungoides;

D O I：

10.3816/CLM.2008.n.034

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Current literature suggests that the incidence of cardiac involvement by lymphoma as identified by autopsy varies widely, ranging from 8.7% to 20%. Historically, many cases might have been clinically undetected; however, improved imaging techniques increasingly identify cardiac involvement incidentally. In addition, newer agents resulting in improved cancer therapy outcomes might alter the prevalence and location of metastatic deposits to include more unusual disease sites, including intracardiac locations. We present 2 cases and a review of the literature.

引用

页码：249 / 252

页数：4

共 42 条

[1]

Abraham K P, 1990, Am J Cardiovasc Pathol, V3, P195

[2]

Abramowitz Yigal, 2007, Int J Cardiol, V118, pe39, DOI 10.1016/j.ijcard.2006.12.039

[3]

Alegre A, 2002, HAEMATOLOGICA, V87, P609

[4]

AlZeerah MA, 2003, TEX HEART I J, V30, P74